Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sequenom Inc announces issuance of European patent for novel methods of detecting fetal aneuploidy


Wednesday, 8 Jan 2014 05:24pm EST 

Sequenom Inc:Says on Jan. 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing, invented by Drs Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong.Says the patent claims novel methods for detecting fetal aneuploidy using sequencing and was the first patent filing made in the EPO directed to such novel methods.Says it holds exclusive rights to the patent, an important part of Sequenom's prenatal diagnostic patent portfolio, with coverage across all countries in the European Union, and also including Liechtenstein, Monaco, Norway and Switzerland. 

Company Quote

3.52
 --
17 Dec 2014